Cargando…

PRRC2A Promotes Hepatocellular Carcinoma Progression and Associates with Immune Infiltration

PURPOSE: Hepatocellular carcinoma (HCC) has high morbidity and poor prognosis due to the propensity of recurrence and metastasis. Emerging studies have confirmed that proline-rich coiled-coil2A (PRRC2A) plays a crucial role in tumorigenesis and immunoregulation. However, its expression status and bi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xin, Zhang, Yize, Wang, Zenghan, Liu, Liwen, Zhang, Guizhen, Li, Jianhao, Ren, Zhigang, Dong, Zihui, Yu, Zujiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646232/ https://www.ncbi.nlm.nih.gov/pubmed/34881207 http://dx.doi.org/10.2147/JHC.S337111

Ejemplares similares

RPL19 Is a Prognostic Biomarker and Promotes Tumor Progression in Hepatocellular Carcinoma
por: Rao, Benchen, et al.
Publicado: (2021)

The tumor microenvironment of hepatocellular carcinoma and its targeting strategy by CAR-T cell immunotherapy
por: Guizhen, Zhang, et al.
Publicado: (2022)

NSUN2 stimulates tumor progression via enhancing TIAM2 mRNA stability in pancreatic cancer
por: Zhang, Guizhen, et al.
Publicado: (2023)

An anoikis-based signature for predicting prognosis in hepatocellular carcinoma with machine learning
por: Guizhen, Zhang, et al.
Publicado: (2023)

Ubiquitin-proteasome system-based signature to predict the prognosis and drug sensitivity of hepatocellular carcinoma
por: Zhang, Jianxiang, et al.
Publicado: (2023)

Analysis of Multi-Layer RNA Modification Patterns for the Characterization of Tumor Immune Microenvironment in Hepatocellular Carcinoma
por: Xing, Jiyuan, et al.
Publicado: (2021)

Expression and clinical significance of miR-3615 in hepatocellular carcinoma
por: Yuan, Xin, et al.
Publicado: (2021)

PRRC2 proteins impact translation initiation by promoting leaky scanning
por: Bohlen, Jonathan, et al.
Publicado: (2023)

Classification molecular subtypes of hepatocellular carcinoma based on PRMT-related genes
por: Liu, Liwen, et al.
Publicado: (2023)

Transcriptional analysis of the expression and prognostic value of lipid droplet-localized proteins in hepatocellular carcinoma
por: Zhang, Yize, et al.
Publicado: (2023)

Determinants of eukaryal cell killing by the bacterial ribotoxin PrrC
por: Meineke, Birthe, et al.
Publicado: (2011)

m6A Regulator-Associated Modification Patterns and Immune Infiltration of the Tumor Microenvironment in Hepatocarcinoma
por: Li, Jianhao, et al.
Publicado: (2021)

The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma
por: Wang, Haiyu, et al.
Publicado: (2020)

Transcriptome-Wide 5-Methylcytosine Functional Profiling of Long Non-Coding RNA in Hepatocellular Carcinoma
por: He, Yuting, et al.
Publicado: (2020)

circPRRC2A promotes angiogenesis and metastasis through epithelial-mesenchymal transition and upregulates TRPM3 in renal cell carcinoma
por: Li, Wei, et al.
Publicado: (2020)

Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma
por: Zhang, Yingying, et al.
Publicado: (2020)

The Role of PRRC2B in Cerebral Vascular Remodeling Under Acute Hypoxia in Mice
por: Li, Shuoshuo, et al.
Publicado: (2023)

A novel m(6)A reader Prrc2a controls oligodendroglial specification and myelination
por: Wu, Rong, et al.
Publicado: (2018)

RNA binding protein PRRC2B mediates translation of specific mRNAs and regulates cell cycle progression
por: Jiang, Feng, et al.
Publicado: (2023)

PrrC-anticodon nuclease: functional organization of a prototypical bacterial restriction RNase
por: Blanga-Kanfi, Shani, et al.
Publicado: (2006)

miR-450b-5p loss mediated KIF26B activation promoted hepatocellular carcinoma progression by activating PI3K/AKT pathway
por: Li, Hua, et al.
Publicado: (2019)

TINAGL1 promotes hepatocellular carcinogenesis through the activation of TGF-β signaling-medicated VEGF expression
por: Sun, Lu, et al.
Publicado: (2019)

Low UGP2 Expression Is Associated with Tumour Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Hu, Qiuyue, et al.
Publicado: (2020)

CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma
por: Su, Jinfang, et al.
Publicado: (2022)

Parallel dimerization of a PrrC-anticodon nuclease region implicated in tRNA(Lys) recognition
por: Klaiman, Daniel, et al.
Publicado: (2007)

The m6A reader PRRC2A is essential for meiosis I completion during spermatogenesis
por: Tan, Xinshui, et al.
Publicado: (2023)

N6-methyladenosine (m6A)-mediated messenger RNA signatures and the tumor immune microenvironment can predict the prognosis of hepatocellular carcinoma
por: Shen, Shen, et al.
Publicado: (2021)

Integrated Bioinformatic Analysis Identifies TIPIN as a Prognostic Biomarker in Hepatocellular Carcinoma
por: Chen, Hui, et al.
Publicado: (2022)

The relationship between cancer and medication exposure in patients with systemic lupus erythematosus: a nested case-control study
por: Guo, Jinyan, et al.
Publicado: (2020)

SLC39A1 Overexpression is Associated with Immune Infiltration in Hepatocellular Carcinoma and Promotes Its Malignant Progression
por: Ma, Xiaowu, et al.
Publicado: (2022)

DPEP1 is a direct target of miR-193a-5p and promotes hepatoblastoma progression by PI3K/Akt/mTOR pathway
por: Cui, Xichun, et al.
Publicado: (2019)

The Heterogeneity of Immune Cell Infiltration Landscape and Its Immunotherapeutic Implications in Hepatocellular Carcinoma
por: Guo, Yuanyuan, et al.
Publicado: (2022)

Characterization of immune infiltration in sarcomatoid hepatocellular carcinoma
por: Luo, Chubin, et al.
Publicado: (2021)

PVR—A Prognostic Biomarker Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma
por: Liu, Wen-Feng, et al.
Publicado: (2022)

Identification of disulfidptosis-related genes with immune infiltration in hepatocellular carcinoma
por: Li, Xiao-min, et al.
Publicado: (2023)

ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma
por: Wang, Zhen-Zhen, et al.
Publicado: (2022)

Overexpression of SH2D1A promotes cancer progression and is associated with immune cell infiltration in hepatocellular carcinoma via bioinformatics and in vitro study
por: Xiang, Qian-Ming, et al.
Publicado: (2023)

Dysbiosis of Gut Microbiota Promotes Hepatocellular Carcinoma Progression by Regulating the Immune Response
por: Zhang, Nan, et al.
Publicado: (2021)

Semaphorin 4B promotes tumor progression and associates with immune infiltrates in lung adenocarcinoma
por: Jiang, Jun, et al.
Publicado: (2022)

RNF135 Promoter Methylation Is Associated With Immune Infiltration and Prognosis in Hepatocellular Carcinoma
por: Wang, Xiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_if2osh6vjv3mdhmb984pen7vfp